Bluefin Capital Management LLC Takes $2.83 Million Position in Integer Holdings Corporation $ITGR

Bluefin Capital Management LLC bought a new position in Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 30,332 shares of the medical equipment provider's stock, valued at approximately $2,835,000. Integer makes up about 0.7% of Bluefin Capital Management LLC's holdings, making the stock its 22nd biggest holding. Bluefin Capital Management LLC owned approximately 0.09% of Integer at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Integer during the second quarter valued at $29,000. EverSource Wealth Advisors LLC lifted its stake in Integer by 48.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider's stock worth $32,000 after purchasing an additional 117 shares in the last quarter. TD Private Client Wealth LLC lifted its stake in Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 415 shares in the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 267 shares during the last quarter. Finally, Arax Advisory Partners boosted its holdings in shares of Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 473 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. Wells Fargo & Company lifted their target price on Integer from $84.00 to $127.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 4th. Benchmark lowered Integer from a "buy" rating to a "hold" rating in a research note on Thursday, August 13th. Weiss Ratings restated a "hold (c)" rating on shares of Integer in a report on Thursday, June 18th. Truist Financial cut Integer from a "buy" rating to a "hold" rating and raised their price target for the company from $110.00 to $127.00 in a report on Monday, August 3rd. Finally, HC Wainwright reaffirmed a "buy" rating on shares of Integer in a report on Friday, July 24th. One analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company's stock. According to MarketBeat, Integer currently has a consensus rating of "Hold" and an average price target of $109.86.

Key Stories Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
• Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
• Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.

Integer Price Performance

Shares of Integer stock opened at $125.32 on Thursday. The stock has a market cap of $4.26 billion, a price-to-earnings ratio of 34.24, a price-to-earnings-growth ratio of 2.96 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. The stock has a 50 day moving average price of $106.20 and a 200-day moving average price of $93.99. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $126.14.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.Integer's quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.55 EPS. Equities analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source